Regulatory
AAON
AAON, Inc. is reaffirming its commitment to the U.S. Department of Energy's Better Buildings Commercial Building Heat Pump Technology Challenge, leveraging strategic partnerships to tackle the challenge with confidence.
Portfolio Pulse from
November 15, 2024 | 1:15 pm
ETNB
89bio presented new analyses at The Liver Meeting® 2024, highlighting the potential benefits of pegozafermin in treating MASH patients. The analyses suggest pegozafermin's anti-fibrotic effects and the utility of non-invasive tests correlating with histological endpoints.
Portfolio Pulse from
November 15, 2024 | 1:15 pm
SMCI
Super Micro Computer Inc. (SMCI) is facing a delisting deadline, which has caused its stock to rise as investors anticipate the company's next move. The situation presents a critical moment for the server maker.
Portfolio Pulse from
November 15, 2024 | 1:15 pm
TDY
Teledyne Controls, a subsidiary of Teledyne Technologies, has announced the certification of its new onboard enhanced Airborne Data Loader (eADL XS™) for the Boeing 737NG aircraft series. Certification for other aircraft platforms is underway.
Portfolio Pulse from
November 15, 2024 | 1:15 pm
IFRX
InflaRx N.V. (Nasdaq: IFRX) has received a positive opinion from the CHMP of the EMA for its drug GOHIBIC (vilobelimab) for treating SARS-CoV-2-induced ARDS. The European Commission is expected to issue a marketing authorization soon.
Portfolio Pulse from
November 15, 2024 | 1:00 pm
TMSNY
Levi & Korsinsky has started an investigation into Temenos AG for potential violations of federal securities laws, following a report by Hindenburg Research alleging accounting irregularities and failed products.
Portfolio Pulse from
November 15, 2024 | 12:45 pm
COUR
Levi & Korsinsky has initiated an investigation into Coursera, Inc. for potential violations of federal securities laws following a revenue miss and lowered guidance in 1Q 2024.
Portfolio Pulse from
November 15, 2024 | 12:45 pm
HRMY
Levi & Korsinsky has initiated an investigation into Harmony Biosciences Holdings, Inc. (HRMY) for potential securities fraud. This follows a report by Scorpion Capital raising concerns about Harmony's narcolepsy drug, Wakix.
Portfolio Pulse from
November 15, 2024 | 12:45 pm
MSFT
Elon Musk has amended a lawsuit against OpenAI to include Microsoft as a defendant, accusing them of forming a monopoly. Reid Hoffman is also added as a defendant.
Portfolio Pulse from
November 15, 2024 | 12:30 pm
DTIL
Precision BioSciences, Inc. (Nasdaq: DTIL) is advancing its gene editing therapy, PBGENE-HBV, for chronic hepatitis B into clinical trials. The company presented preclinical data and outlined the design for its first-in-human study, ELIMINATE-B.
Portfolio Pulse from
November 15, 2024 | 12:15 pm
Previous
Next